Programmed Cell Death Protein 4 (PDCD4) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) Antibody is a Rabbit Polyclonal antibody against Programmed Cell Death 4 (Neoplastic Transformation Inhibitor).
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | Programmed Cell Death Protein 4 (PDCD4) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Antigen Affinity Chromatography. |
Size 1 | 100 µl |
Form | Liquid |
Tested Applications | ELISA, WB, IHC |
Buffer | PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q53EL6 |
Gene ID | 27250 |
NCBI Accession | NP_055271.2, NM_014456.4, NP_663314.1, NM_145341.3 |
OMIM | 608610 |
Background | Antibody anti-PDCD4 |
Status | RUO |
Descripción
Related Products

Human PDCD4 (Programmed cell death protein 4) ELISA Kit
Ver Producto
PDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver Producto
PDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver Producto